Biological and Pharmaceutical Bulletin
Online ISSN : 1347-5215
Print ISSN : 0918-6158
ISSN-L : 0918-6158
Involvement of Protease Inhibitors in Staphylokinase-Induced Fibrin-Specific Fibrinolysis
Yoshiyuki SHISHIDOMasashi SAKAINorimasa KANEDAHiroshi SANSAWAKisaku SHIMURASyusuke HASHIMOTOTeruo YOKOKURA
Author information
JOURNAL FREE ACCESS

1994 Volume 17 Issue 12 Pages 1595-1598

Details
Abstract

We compared the fibrinolytic properties of recombinant staphylokinase (SAK), a fibrin-specific plasminogen activator, with those of streptokinase and tissue-type plasminogen activator (t-PA) by means of the amidolytic method. We also investigated the involvement of α2-macroglobulin, C1-inactivator and α1-antitrypsin in SAK-induced fibrin-specific fibrinolysis. Both SAK and t-PA activated plasminogen efficiently in the presence of fibrin in human plasma. Although t-PA activated plasminogen dependently on fibrin in the reconstituted plasma system, SAK activated plasminogen independently of fibrin without α2-plasmin inhibitor (α2-antiplasmin, α2-PI). These findings suggest that fibrin and α2-PI play important roles in plasminogen activation by SAK but not by t-PA. Furthermore, protease inhibitors such as α2-PI, α2-macroglobulin, C1-inactivator and α1-antitrypsin inhibited plasminogen activation by SAK and the inhibitory actions of these protease inhibitors disappeared in the presence of fibrin. This shows that α2-macroglobulin, C1-inactivator and α1-antitrypsin, other than α2-PI, contribute to the fibrin-specificity of SAK.

Content from these authors
© The Pharmaceutical Society of Japan
Previous article Next article
feedback
Top